Market Tracker

09/28 5:48pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.39
Delayed Data
As of 3:59pm ET
 -0.01 / -0.29%
Today’s Change
1.50
Today|||52-Week Range
5.44
+10.42%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.40
Today’s open3.40
Day’s range3.06 - 3.41
Volume1,038,016
Average volume (3 months)1,868,343
Market cap$325.9M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+23.39%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.01+0.08%
LNTHLantheus Holdings In...+0.05+0.61%
OXFDOxford Immunotec Glo...-0.03-0.24%
QTNTQuotient Ltd-0.08-1.00%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts